Australasian Neonatal Medicines Formulary

The drug guidelines and other documents in the Australasian Neonatal Medicines Formulary (ANMF) are produced after thorough review of the literature relevant to the use of each drug in the neonate. They are constructed with a view to use of the medications within the New South Wales legal framework and within the medical environment of Newborn Intensive Care. The guidelines are reviewed on a regular basis, but there is no claim that all current regulatory or safety warnings have been added. Care should be taken that the most up to date version of ANMF is being used. Although all care is taken in the production of these guidelines, no responsibility is accepted regarding the use of ANMF and no liability is accepted to any consequences resulting from following the recommendations of this product.

PLEASE NOTE: Formularies marked with an asterisk (*) are for exclusive use within the Neonatal Intensive Care at the Royal Prince Alfred Hospital and have not been reviewed by ANMF group.

Acetylcysteine

Amoxicillin-clavulanate

Amphotericin

Amphotericin (Liposomal)

Cyclopentolate eye drops

Hepatitis B Immunoglobulin

Insulin Hyperglycaemia

Insulin Hyperkalaemia

Isoprenaline Infusion

LevETIRAcetam

Liothyronine

Noradrenaline Infusion

Normal Saline

Nystatin

Omeprazole

Oxybuprocaine eye drops

Palivizumab (RSV-immunoglobulin)

Phenylephrine Eye Drops

Phosphorus

Piperacillin/Tazobactam

Prevenar

Propranolol (cardiovascular)

Propranolol (For Infantile Haemangioma)

Pyridoxone*

Ranitidine

Remifentanil

Sodium Chloride 23.4%

Sotalol

Spironolactone

Sucrose

Sulfamethoxazole and Trimethoprim

Survanta (Beractant)

Suxamethonium

Synacthen (for test)*

Thyroxine (oral)

Thyroxine preparation for infants and children

Vancomycin continuous infusion

Vancomycin intermittent dosage

Unless otherwise stated, the contents of this publication are licensed under the Creative Commons Attribution-Noncommercial 4.0 licence, except as noted below. Terms and conditions of the licence can be viewed at https://creativecommons.org/licenses/by-nc/4.0/

We also request that you observe and retain any copyright or related notices that may accompany this material as part of the attribution.

Material not licensed under the Creative Commons Licence

The following material in this publication is not licensed under the Creative Commons Licence:

1. The State’s Coat of Arms and any other symbols, logos or trademarks of the State of NSW of any Department or Agency of the State (unless incidentally reproduced in using an unaltered document under the Creative Commons licence).

2. Any third-party material unless expressly stated to be published under the Creative Commons Licence. (Note that such material may not be expressly identified, although as a general policy we do aim to do so).

The State of New South Wales accepts no responsibility for any modification, redistribution or use of the formulary or any part thereof. The formulary is expressly intended for use by NSW Health staff when performing duties and delivering health care for, and on behalf of, NSW Health.

Under no circumstances will the State of New South Wales, its employees or agents, be liable for any loss, injury, claim, liability or damages of any kind resulting from the unauthorised use of, or reliance upon the formulary or its contents.

Disclaimer

Copyright statement

For any content related matters on this section, please contact RPAH Neonatal Formulary Director, Dr David Osborn.